DMEPOS Oversight Moves Upstream
The Centers for Medicare & Medicaid Services (CMS) has announced that starting October 15, 2026, it will “require probationary prior authorization for certain DMEPOS items billed by newly…
Read moreThe Centers for Medicare & Medicaid Services (CMS) has announced that starting October 15, 2026, it will “require probationary prior authorization for certain DMEPOS items billed by newly…
Read moreOn April 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year (FY) 2027 Prospective Payment System (PPS) and Consolidated Billing for Skilled Nursing…
Read moreAs Applied Policy has previously reported, on February 25, 2026, the Trump Administration announced several initiatives as part of a broader effort to address healthcare fraud. These included…
Read moreOn February 25, 2026, the Trump Administration announced several initiatives as part of a broader effort to address health care fraud. This includes a Nationwide Durable Medical Equipment,…
Read moreOn July 23, 2025, the U.S. Food and Drug Administration (FDA) and U.S. Department of Agriculture (USDA) announced a joint Request for Information (RFI) requesting data and comments to…
Read moreIt has been just over a month since the Food and Drug Administration announced the agency-wide rollout of Elsa a generative AI tool “designed to help employees—from scientific…
Read moreThe Trump Administration is using executive actions, agency initiatives, and policy directives to reduce or eliminate animal testing in medical research and to promote the adoption of alternative…
Read moreOn January 23, 2025, President Trump issued Executive Order 14179 on Removing Barriers to American Leadership in Artificial Intelligence. This followed his revocation of the Biden Administration’s Executive…
Read moreOn November 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule for calendar year (CY)…
Read more